Bausch Health Companies | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Amgen USD 11.97B 2.96B 2024-12
ANI Pharmaceuticals USD 144.86M 121K 2024-12
Aurora Cannabis CAD 108.71M 23.79M 2024-12
Bausch Health Companies USD 1.13B 47M 2025-03
Biogen USD 2.38B 675.8M 2024-12
Bristol-Myers Squibb USD 10.88B 529M 2025-03
Canopy Growth CAD 16.31M 69.8M 2024-12
Corcept Therapeutics USD 127.66M 9.62M 2024-12
Danaher USD 1.99B 85M 2025-03
Drreddys Laboratories INR 1.1B 743M 2024-12
Eli Lilly USD 3.09B 175.1M 2025-03
Gilead Sciences USD 7.93B 2.06B 2025-03
Pacira USD 276.77M 30.81M 2024-12
Perrigo USD 558.8M 904.7M 2024-12
Prestige Brands USD 50.87M 666K 2024-12
Supernus Pharmaceuticals USD 69.33M 37.66M 2024-12
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12
Zoetis USD 1.98B 275M 2024-12



Bausch Health Companies Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.